Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04986566 · ClinicalTrials.gov registry record · NA
Perioperative Telemonitoring to Optimize Cancer Care and Outcomes
A NA study of Malignant Digestive System Neoplasm, sponsored by City of Hope Medical Center.
- Active
- Registry status
- NA
- Development phase
- 134
- Enrollment target
- 1
- Study location
NCT04986566: Active NA study of Malignant Digestive System Neoplasm, sponsored by City of Hope Medical Center.
NCT04986566 is a NA study of Malignant Digestive System Neoplasm that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 134 participants, below the 678-participant average among 11 other Malignant Digestive System Neoplasm trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04986566, a NA study of Malignant Digestive System Neoplasm, is active but no longer recruiting, sponsored by City of Hope Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to see whether an at-home monitoring program that collects health, symptoms, and quality of life data in real-time can be included as part of the care of surgery patients in order to provide better recovery. Patient-generated health data (weight, temperature, oxygen level, heart rate, blood pressure, daily steps, symptoms, quality of life) using at-home monitoring devices (thermometer, a pulse oximeter, a digital scale and a Vivofit 4 watch) and smart device applications are used more and more to measure value and quality in cancer care. However, measuring patient-generated health data is not currently part of standard care following cancer surgery. An at-home monitoring program may improve the care of patients after hospital discharge from surgery and may help reduce complications by identifying issues early.
Primary Outcome
Postoperative complications occurring within 30 days post-discharge after cancer surgery were measured using the Comprehensive Complications index (CCI), a validated tool that aggregates the Clavien grades of postoperative complications on a continuous scale ranging from 0 (no complication) to 100 (death).
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Medical Device Usage and Evaluation
- OTHER Best Practice
- BEHAVIORAL Health Education
Study Locations (1)
California
- City of Hope Medical Center - Duarte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2021-10-19 |
| Est. Completion | 2026-02-07 |
| Phase | NA |
What the registry record for NCT04986566 still lists
NCT04986566 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 678-participant average among 11 other Malignant Digestive System Neoplasm trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Malignant Digestive System Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04986566 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04986566 about?
NCT04986566 is a clinical study titled "Perioperative Telemonitoring to Optimize Cancer Care and Outcomes". This study aims to see whether an at-home monitoring program that collects health, symptoms, and quality of life data in real-time can be included as part of the care of surgery patients in order to provide better recovery. Patient-generated health data (weight, temperature, oxygen level, heart rate...
What is the current status of trial NCT04986566?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 134 participants. The study started on 2021-10-19. Estimated completion is 2026-02-07.
What conditions does trial NCT04986566 study?
This clinical trial studies the following conditions: Malignant Digestive System Neoplasm.
What interventions are being tested in trial NCT04986566?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Medical Device Usage and Evaluation (OTHER), Best Practice (OTHER), Health Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT04986566?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04986566 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Digestive System Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04986566's enrollment target sits among peer trials
134 5th of 11 higher than 7 of 11 other Malignant Digestive System Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Digestive System Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies
ACTIVE NOT RECRUITING · NA
-
Narrative Medicine for Improving Well-Being in Patients With Gastrointestinal Cancers
COMPLETED · NA
-
Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer
RECRUITING · Phase 2
-
Molecular Epidemiology of Biliary Tree Cancers
RECRUITING
-
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
RECRUITING
-
2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI